More than 90% of HNSCC patients were tested positive for epidermal growth factor receptor (EGFR) (55), which is highly expressed in a variety of solid tumors and triggers an intracellular growth factor transduction cascade to regulate cell growth (56, 57). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.